Sclérose en plaques agressive: Définition et indication thérapeutique particulière
- 29 February 2004
- journal article
- research article
- Published by Elsevier in La Presse Médicale
- Vol. 33 (3) , 187-191
- https://doi.org/10.1016/s0755-4982(04)98520-x
Abstract
No abstract availableKeywords
This publication has 9 references indexed in Scilit:
- Mitoxantrone in progressive multiple sclerosis: when and how to treat?Journal of the Neurological Sciences, 2003
- Mitoxantrone in progressive multiple sclerosis: a placebo-controlled, double-blind, randomised, multicentre trialThe Lancet, 2002
- Cardiac adverse effects associated with mitoxantrone (Novantrone) therapy in patients with MSNeurology, 2002
- Escalating Immunotherapy of Multiple SclerosisEuropean Neurology, 1999
- Randomized placebo-controlled trial of mitoxantrone in relapsing-remitting multiple sclerosis: 24-month clinical and MRI outcomeZeitschrift für Neurologie, 1997
- Therapeutic effect of mitoxantrone combined with methylprednisolone in multiple sclerosis: a randomised multicentre study of active disease using MRI and clinical criteria.Journal of Neurology, Neurosurgery & Psychiatry, 1997
- Suppression of acute and relapsing experimental allergic encephalomyelitis with mitoxantroneClinical Immunology and Immunopathology, 1987
- Regional suppression, therapy after onset and prevention of relapses in experimental allergic encephalomyelitis by mitoxantroneJournal of Neuroimmunology, 1986
- Suppression of experimental allergic encephalomyelitis by mitoxantroneClinical Immunology and Immunopathology, 1985